Drug Patent Watch

DECEMBER 12, 2024

Biosimilars and Complex Generics The rise of biosimilars and complex generics is changing the dynamics of market exclusivity. Staying informed about future trends, such as biosimilars and personalized medicine, is crucial for adapting strategies.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 96

European Pharmaceutical Review

FEBRUARY 20, 2024

Based on the report’s data, the market is also advancing due to greater amount of research being conducted on the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides.

Process Improvement 98

Process Improvement Biosimilars Drug Development 98

Express Pharma

OCTOBER 9, 2024

He put forth the importance of Research and Development and regulatory systems, particularly for the deeper work needed in the biologics and biosimilar space. He praised the reforms undertaken by the Government in the last decade, which have helped the industry thrive, particularly through structural and process improvements.

Vaccines 105

Vaccines Process Improvement Biosimilars Immunity 105

Express Pharma

JULY 10, 2024

Sasmitha Sahu, Managing Consultant, GlobalData states, “While India has demonstrated success in generic drug production, the same is not true for novel and biosimilar biopharma products.”

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96